Corrigendum to "Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides" [Bioorg. Med. Chem. Lett. 27(23) (2017) 5179-5184].
Corrigendum to "Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides" [Bioorg. Med. Chem. Lett. 27(23) (2017) 5179-5184].
复制标题
“M4 PAM 临床前候选药物开发中的挑战：一系列氮杂环丁烷衍生的叔酰胺的发现、SAR 和生物学特性”的勘误 [Bioorg.
DOI：
10.1016/j.bmcl.2018.07.022
复制
发表时间：
2018
影响因子：
2.7
通讯作者：
Brando
中科院分区：
文献类型：
--
作者：
Tarr,JamesC;Wood,MichaelR;Noetzel,MeredithJ;Melancon,BruceJ;Lamsal,Atin;Luscombe,VincentB;Rodriguez,AliceL;Byers,FrankW;Chang,Sichen;Cho,HyekyungP;Engers,DarrenW;Jones,CarrieK;Niswender,ColleenM;Wood,MichaelW;Brando
The authors regret the incorrect format of the name of one of the authors on the original version of the manuscript. The authors would like to apologise for any inconvenience caused.
